The European training network PHAST (Photonics for Healthcare: multiscAle cancer diagnosiS and Therapy) offers 15 early stage researchers (ESR) a strong multidisciplinary PhD program in the dynamic field of biophotonics. During an engagement week, the ESRs gained insights into translating research into medical technology products. Leibniz Health Technologies and InfectoGnostics organized a day on market introduction and reimbursement for this purpose.
After an introduction by Dr. Jens Hellwage on trends and models of cooperation in public-private partnerships for innovations in medical technology, Dr. Simon Reif from LGT partner ZEW - Leibniz Centre for European Economic Research discussed with the participants ways and hurdles for the introduction of new technologies from an economic perspective.
Subsequently, Dr. Robby Markwart and Anni Matthes from the Jena University Hospital (Project Group POCT-ambulant) showed reimbursement pathways for the introduction of IVD/medical devices and novel technologies in Germany and Europe, so that the international Early Stage Researchers gained insights into the German and European healthcare and reimbursement system.